In memory of Allison Dunn, we are proud to share that $300,000 in research funding dedicated to brain tumours and glioblastoma has been awarded. This impactful investment includes a $100,000 Elevation Grant, a $100,000 fellowship, and renewed second-year funding for two Elevation Grant projects already underway.

This meaningful progress has been made possible through our partnership with Wayne Dunn and the Dunn family, who continue to transform grief into action and create lasting impact in Allison’s name.

Allison passed away on June 17, 2020, at just 33 years old, after a courageous battle with glioblastoma (GBM). She was a devoted mother of three, a loving daughter, sister, friend, and a compassionate soul whose strength and generosity touched the lives of countless others. Even in the face of unimaginable adversity, Allison remained focused on others, offering comfort, support, and hope. Her legacy lives on not only through her children and loved ones, but also through the vital work being carried forward in her honour.

Advancing brain cancer research in Allison’s honour

The Elevation Research Grant was awarded to Dr. Ana Nikolic, assistant professor at the University of Calgary’s Cumming School of Medicine. Dr. Nikolic’s research explores cellular quiescence in adult IDH-wildtype glioblastoma, contributing important insights into this aggressive disease.

The Fellowship Research Grant was awarded to Dr. Lauren Westhaver, a postdoctoral research fellow at Dalhousie University. Her innovative work focuses on immune cell profiling to distinguish true glioblastoma progression from pseudoprogression, thereby helping to improve treatment decision-making and outcomes for patients and their families.

We are also proud to continue funding two promising ongoing Elevation Grant projects:

• Dr. Scott Bratman (Princess Margaret Cancer Research Institute), whose cfDNA technology is advancing non-invasive diagnostics for high-grade gliomas; and
• Dr. Adrienne Weeks (Dalhousie Univerity), who is using flow cytometry to monitor immune cell profiles in tumour tissue and blood over time, helping distinguish treatment effects from tumour progression.

Each of these projects reflects Allison’s spirit: bold, compassionate, and forward-looking. They represent real hope for those affected by glioblastoma.

A legacy of love and impact

As we mark five years since Allison’s passing, we are reminded that every step forward in research is both a tribute to those we’ve lost and a promise to those still fighting. Through our partnership with the DUNN with Cancer family, Allison’s story continues to inspire critical research and meaningful change across Canada.

To the entire DUNN with Cancer family, thank you. Your unwavering commitment and generosity have created a powerful legacy in Allison’s honour. Together, we continue this work for Allison, and for every mother, sister, daughter, and friend whose story deserves more time, more answers, and more hope.